
News|Podcasts|April 14, 2025
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
Author(s)Alexandra Gerlach, Associate Editor
Pharmacists share key insights about the use of ADCs for treatment of breast cancer.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First At-Home Treatment Device for Depression
2
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
3
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP-2–Targeted Therapy
4
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
5

















































































































































































































